Press Release

Morgan Lewis Advises Reify Health in $220M Series D Round

Thursday, April 21, 2022

BOSTON, April 21, 2022: Morgan Lewis represented Reify Health, a provider of solutions empowering faster, predictable, and more accessible clinical trials, in the company’s $220 million Series D round.

Morgan Lewis partner Carl Valenstein, and associates Benjamin Stein and Bryan Judd advised Reify Health. The firm previously advised Reify Health on a $220 million Series C round in 2021.

Read Reify Health’s announcement.